Apogee Therapeutics Inc (APGE) PT Raised to $135 at Truist Securities
Tweet
Share
E-mailGet Alerts APGE Hot Sheet
Price: $135.07 --0%
Rating Summary:
5 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Rating Summary:
5 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Join SI Premium – FREE
Truist Securities analyst Danielle Brill raised the price target on Apogee Therapeutics Inc (NASDAQ: APGE) to $135.00 (from $81.00) while maintaining a Hold rating.
You May Also Be Interested In
- RBC Capital Downgrades LVMH (MC:FP) (LVMUY) to Sector Perform
- Lupin (LPC:IN) PT Lowered to INR2,500 at HSBC
- EssilorLuxottica SA (EL:FP) (ESLOY) PT Lowered to EUR190 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
